Certara Products - Certara IQ Archives

Guide

De-Risking Drug Design: How Early Feasibility Assessment Transforms Biotherapeutic Development

Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…

CertaraNovember 7, 2025

Publication

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…

Danielle PillsburyNovember 7, 2025

Press Release

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

CertaraOctober 30, 2025

Blog

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

QSP modeling holds huge promise, but complexity and scalability limit adoption. We review the challenges…

CertaraOctober 22, 2025

Video

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Explore how Certara IQ redefines QSP modeling through automation, scalability, and AI assistance for faster,…

CertaraOctober 16, 2025

Video

Immuno-oncology (IO) Simulator in Certara IQ™

Learn how Certara IQ’s IO Simulator models immune-tumor interactions and therapy outcomes to guide immuno-oncology…

CertaraOctober 16, 2025

Video

ADC Modeling and Design with Certara IQ™

Discover how Certara IQ helps optimize antibody-drug conjugate properties through mechanistic modeling and early feasibility…

CertaraOctober 16, 2025

Video

Prebuilt Pharmacology Models in Certara IQ™

Certara IQ Pharmacology Models | Prebuilt Mechanistic Models for Faster QSP Research

CertaraOctober 16, 2025

Video

QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™

Learn how Certara IQ’s IBD model enables simulation of complex immune pathways to optimize therapeutic…

CertaraOctober 16, 2025

Video

Modeling Alzheimer’s Disease with Certara IQ™

Explore Certara IQ’s Alzheimer’s Disease model, enabling researchers to simulate neurodegenerative pathways, test therapies, and…

CertaraOctober 16, 2025

Certara Products – Certara IQ

De-Risking Drug Design: How Early Feasibility Assessment Transforms Biotherapeutic Development

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Bottlenecks to Breakthroughs: Tackling Challenges in QSP Modeling

Certara IQ™: The Future of AI-Enabled Scalable QSP Modeling

Immuno-oncology (IO) Simulator in Certara IQ™

ADC Modeling and Design with Certara IQ™

Prebuilt Pharmacology Models in Certara IQ™

QSP Modeling for Inflammatory Bowel Disease (IBD) with Certara IQ™

Modeling Alzheimer’s Disease with Certara IQ™

Newsletter sign up

Quick links

Solutions

Contact